You are visiting the WFDD web archives.
Click here to return to our main website with the latest news from WFDD and NPR. |
Search the WFDD archives
|
The Business Report
High Point Company Ponders Next Move on Alzheimer's Drug
November 2, 2012 | Audrey Fannin
A High Point pharmaceutical company is at a critical juncture: whether it will continue the clinical trial process on it's Alzheimer's drug alone, abandon the process or look for a new financial partner.
Full archive of The Business Report >>
Headlines for November 6, 2012
|
|
|
|
